Compare MDLZ & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDLZ | HCA |
|---|---|---|
| Founded | 2000 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Hospital/Nursing Management |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.1B | 93.7B |
| IPO Year | 2001 | 2009 |
| Metric | MDLZ | HCA |
|---|---|---|
| Price | $64.04 | $462.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 26 |
| Target Price | $69.05 | ★ $460.59 |
| AVG Volume (30 Days) | ★ 7.0M | 1.2M |
| Earning Date | 10-29-2026 | 10-27-2026 |
| Dividend Yield | ★ 3.30% | 0.67% |
| EPS Growth | N/A | ★ 28.77 |
| EPS | 0.44 | ★ 7.15 |
| Revenue | $38,537,000,000.00 | ★ $75,600,000,000.00 |
| Revenue This Year | $4.06 | $3.85 |
| Revenue Next Year | $2.82 | $3.91 |
| P/E Ratio | $143.25 | ★ $65.54 |
| Revenue Growth | 5.75 | ★ 7.08 |
| 52 Week Low | $51.20 | $353.99 |
| 52 Week High | $66.65 | $556.52 |
| Indicator | MDLZ | HCA |
|---|---|---|
| Relative Strength Index (RSI) | 66.61 | 65.96 |
| Support Level | $60.34 | $460.33 |
| Resistance Level | $66.10 | $487.09 |
| Average True Range (ATR) | 1.09 | 10.11 |
| MACD | 0.58 | 2.83 |
| Stochastic Oscillator | 91.36 | 70.38 |
Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012. Since that time, the firm has been a leading player in the global snack enclave with a presence in the biscuit (48% of sales as of the end of fiscal 2025), chocolate (33%), gum/candy (10%), beverage (3%), and cheese and grocery (6%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury. The firm garners around one-third of its revenue from developing markets, around 40% from Europe, and more than one-fourth from North America.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.